AUPR665401A0 - A drug and method for the treatment of osteonecrosis - Google Patents

A drug and method for the treatment of osteonecrosis

Info

Publication number
AUPR665401A0
AUPR665401A0 AUPR6654A AUPR665401A AUPR665401A0 AU PR665401 A0 AUPR665401 A0 AU PR665401A0 AU PR6654 A AUPR6654 A AU PR6654A AU PR665401 A AUPR665401 A AU PR665401A AU PR665401 A0 AUPR665401 A0 AU PR665401A0
Authority
AU
Australia
Prior art keywords
osteonecrosis
drug
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AUPR6654A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Royal Alexandra Hospital for Children
Original Assignee
Royal Alexandra Hospital for Children
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Royal Alexandra Hospital for Children filed Critical Royal Alexandra Hospital for Children
Priority to AUPR6654A priority Critical patent/AUPR665401A0/en
Publication of AUPR665401A0 publication Critical patent/AUPR665401A0/en
Priority to US10/470,924 priority patent/US7425549B2/en
Priority to CA2435552A priority patent/CA2435552C/en
Priority to DE60143964T priority patent/DE60143964D1/en
Priority to SK986-2003A priority patent/SK9862003A3/en
Priority to SI200130991T priority patent/SI1365769T1/en
Priority to HU0303013A priority patent/HUP0303013A3/en
Priority to DK01273650.0T priority patent/DK1365769T3/en
Priority to JP2002562358A priority patent/JP2004527479A/en
Priority to AT01273650T priority patent/ATE496624T1/en
Priority to EP01273650A priority patent/EP1365769B1/en
Priority to PL36190901A priority patent/PL361909A1/en
Priority to PCT/AU2001/001616 priority patent/WO2002062351A1/en
Priority to BR0116862-2A priority patent/BR0116862A/en
Priority to NZ527351A priority patent/NZ527351A/en
Priority to CNB018225365A priority patent/CN1233325C/en
Priority to KR10-2003-7010328A priority patent/KR20030072399A/en
Priority to AU2002221339A priority patent/AU2002221339B2/en
Priority to CZ20032408A priority patent/CZ301361B6/en
Priority to MXPA03007029A priority patent/MXPA03007029A/en
Priority to ZA2003/05890A priority patent/ZA200305890B/en
Priority to IL157201A priority patent/IL157201A/en
Priority to NO20033446A priority patent/NO20033446L/en
Priority to HK04103953.5A priority patent/HK1061797A1/en
Priority to US12/191,264 priority patent/US7612050B2/en
Priority to CY20111100406T priority patent/CY1111402T1/en
Abandoned legal-status Critical Current

Links

AUPR6654A 2001-02-06 2001-07-27 A drug and method for the treatment of osteonecrosis Abandoned AUPR665401A0 (en)

Priority Applications (26)

Application Number Priority Date Filing Date Title
AUPR6654A AUPR665401A0 (en) 2001-07-27 2001-07-27 A drug and method for the treatment of osteonecrosis
MXPA03007029A MXPA03007029A (en) 2001-02-06 2001-12-13 A drug for the treatment of osteonecrosis and for the management of patients at risk of developing osteonecrosis.
PCT/AU2001/001616 WO2002062351A1 (en) 2001-02-06 2001-12-13 A drug for the treatment of osteonecrosis and for the management of patients at risk of developing osteonecrosis
NZ527351A NZ527351A (en) 2001-02-06 2001-12-13 Use of bisphosphonate for the treatment of osteonecrosis and for the management of patients at risk of developing ostenonecrosis
DE60143964T DE60143964D1 (en) 2001-02-06 2001-12-13 DRUGS TO TREAT OSTEONE COSMETICS AND TO SUPPLY PATIENTS WITH RISK TO OSTEONE CRYOSIS
SK986-2003A SK9862003A3 (en) 2001-02-06 2001-12-13 A drug for the treatment of osteonecrosis and for the management of patients at risk of developing osteonecrosis
SI200130991T SI1365769T1 (en) 2001-02-06 2001-12-13 A drug for the treatment of osteonecrosis and for the management of patients at risk of developing osteonecrosis
HU0303013A HUP0303013A3 (en) 2001-02-06 2001-12-13 A drug for treatment of osteonecrosis and for the management of patients at risk developing osteonecrosis
DK01273650.0T DK1365769T3 (en) 2001-02-06 2001-12-13 Drug for the treatment of osteonecrosis and for the treatment of patients at risk of developing osteonecrosis
JP2002562358A JP2004527479A (en) 2001-02-06 2001-12-13 Medication for the treatment of osteonecrosis and for the management of patients at risk of developing osteonecrosis
AT01273650T ATE496624T1 (en) 2001-02-06 2001-12-13 MEDICINAL PRODUCTS FOR THE TREATMENT OF OSTEONECROSIS AND FOR THE CARE OF PATIENTS AT RISK OF DEVELOPING OSTEONECROSIS
EP01273650A EP1365769B1 (en) 2001-02-06 2001-12-13 A drug for the treatment of osteonecrosis and for the management of patients at risk of developing osteonecrosis
PL36190901A PL361909A1 (en) 2001-02-06 2001-12-13 A drug for the treatment of osteonecrosis and for the management of patients at risk of developing osteonecrosis
US10/470,924 US7425549B2 (en) 2001-02-06 2001-12-13 Drug for the treatment of osteonecrosis and for the management of patients at risk of developing osteonecrosis
BR0116862-2A BR0116862A (en) 2001-02-06 2001-12-13 Medication, methods to treat a patient with osteonecrosis and / or osteochondritis dissecans, to prevent osteonecrosis and / or osteochondritis dissecans in a patient at risk for each of said diseases, use of a medication, and, method to prevent cartilage destruction or chondrolysis associated with osteonecrosis and / or osteochondritis dissecans
CA2435552A CA2435552C (en) 2001-02-06 2001-12-13 A drug for the treatment of osteonecrosis and for the management of patients at risk of developing osteonecrosis
CNB018225365A CN1233325C (en) 2001-02-06 2001-12-13 Drug for treatment of osteonecrosis and for management of patients at risk of evelopment osteonecrosis
KR10-2003-7010328A KR20030072399A (en) 2001-02-06 2001-12-13 A drug for the treatment of osteonecrosis and for the management of patients at risk of developing osteonecrosis
AU2002221339A AU2002221339B2 (en) 2001-02-06 2001-12-13 A drug for the treatment of osteonecrosis and for the management of patients at risk of developing osteonecrosis
CZ20032408A CZ301361B6 (en) 2001-02-06 2001-12-13 Medicament for the treatment of osteonecrosis and osteochondritis dissecans
ZA2003/05890A ZA200305890B (en) 2001-02-06 2003-07-30 A drug for the treatment of osteonecrosis and for the management of patients at risk of developing osteonecrosis
IL157201A IL157201A (en) 2001-02-06 2003-07-31 Drug for the treatment of osteonecrosis and for the management of patients at risk of developing osteonecrosis
NO20033446A NO20033446L (en) 2001-02-06 2003-08-04 Medication for the treatment of osteonecrosis and for the treatment of patients at risk of developing osteonecrosis
HK04103953.5A HK1061797A1 (en) 2001-02-06 2004-06-02 A drug for the treatment of osteonecrosis and for the management of patients at risk of developing osteonecrosis
US12/191,264 US7612050B2 (en) 2001-02-06 2008-08-13 Drug for the treatment of osteonecrosis and for the management of patients at risk of developing osteonecrosis
CY20111100406T CY1111402T1 (en) 2001-02-06 2011-04-20 MEDICINE FOR OSTONEECONOMY TREATMENT AND FOR MANAGEMENT OF PATIENT MECHANISMS OF OSTONEECONOSIS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPR6654A AUPR665401A0 (en) 2001-07-27 2001-07-27 A drug and method for the treatment of osteonecrosis

Publications (1)

Publication Number Publication Date
AUPR665401A0 true AUPR665401A0 (en) 2001-08-16

Family

ID=3830610

Family Applications (1)

Application Number Title Priority Date Filing Date
AUPR6654A Abandoned AUPR665401A0 (en) 2001-02-06 2001-07-27 A drug and method for the treatment of osteonecrosis

Country Status (1)

Country Link
AU (1) AUPR665401A0 (en)

Similar Documents

Publication Publication Date Title
AU2002330041A1 (en) Method and device for the iontophoretic delivery of a drug
AU2003256253A1 (en) Aerosol for medical treatment and methods
AU2002322524A1 (en) Drug calendar apparatus and method
AU2002315094A1 (en) Method and apparatus for improved patient care
AU2002326600A1 (en) Side-exit catheter and method for its use
AU2003282580A1 (en) Contrast therapy system and method
AU2003249716A1 (en) Method and system for increasing the efficacy of a clinical trial
AU2002345612A1 (en) Ultrasound-fluoroscopic seed therapy system and method
AU2002341959A1 (en) Drug delivery devices and methods
WO2003056491A8 (en) Method and apparatus for clinical trials
AU2002303283A1 (en) Methods for treating drug addiction
AU2002357351A1 (en) Implantable medical device and method for manufacturing the same
AU2002349630A1 (en) Medical treatment system and production method therefor
AU2002247690A1 (en) Transdermal therapeutic system containing testosterone and method for the production thereof
AU2002309083A1 (en) Method for identifying drugs for the treatment of type ii diabetes
AU2002349268A1 (en) Medicine for preventing and treating bromidrosis
AU2002313946A1 (en) Method for curing immunopathosis and medicinal agent for carrying out said method
AU2003268939A1 (en) Bisphosphonates for the treatment of antheroscleorosis and devices comprising them
AUPR665401A0 (en) A drug and method for the treatment of osteonecrosis
AU2002101010A4 (en) Treatment process and apparatus
AU2002324193A1 (en) Therapeutic insert and therapeutic method
AUPR537101A0 (en) A method of assessment and treatment
AU2003291882A1 (en) Pharmaceutical combinations and methods for the treatment of leukemia
AU2002355186A1 (en) Method of administering drugs and devices for same
AU2002240883A1 (en) System and method for improving the medical treatment of a patient